Hydroxylated Tropolones Inhibit Hepatitis B Virus Replication by Blocking Viral Ribonuclease H Activity

Hepatitis B virus (HBV) remains a major human pathogen despite the development of both antiviral drugs and a vaccine, in part because the current therapies do not suppress HBV replication far enough to eradicate the virus. Here, we screened 51 troponoid compounds for their ability to suppress HBV RN...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Antimicrob Agents Chemother
Autores principales: Lu, Gaofeng, Lomonosova, Elena, Cheng, Xiaohong, Moran, Eileen A., Meyers, Marvin J., Le Grice, Stuart F. J., Thomas, Craig J., Jiang, Jian-kang, Meck, Christine, Hirsch, Danielle R., D'Erasmo, Michael P., Suyabatmaz, Duygu M., Murelli, Ryan P., Tavis, John E.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2015
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335860/
https://ncbi.nlm.nih.gov/pubmed/25451058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.04617-14
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares